Intervention Review

Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia

  1. Pranav S. Garimella2,
  2. Howard A Fink3,
  3. Roderick MacDonald1,
  4. Timothy J Wilt1,*

Editorial Group: Cochrane Prostatic Diseases and Urologic Cancers Group

Published Online: 7 OCT 2009

Assessed as up-to-date: 15 JUN 2009

DOI: 10.1002/14651858.CD007360.pub2

Database Title

Additional Information

How to Cite

Garimella PS, Fink HA, MacDonald R, Wilt TJ. Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia. Cochrane Database of Systematic Reviews 2009, Issue 4. Art. No.: CD007360. DOI: 10.1002/14651858.CD007360.pub2.

Author Information

  1. 1

    VAMC, General Internal Medicine (111-0), Minneapolis, Minnesota, USA

  2. 2

    John H. Stroger Hospital of Cook County, Chicago, Illinois, USA

  3. 3

    VA Medical Center, Geriatric Research Education and Clinical Center, Box 11G, Minneapolis, Minnesota, USA

*Timothy J Wilt, General Internal Medicine (111-0), VAMC, One Veterans Drive, Minneapolis, Minnesota, 55417, USA. Tim.Wilt@med.va.gov.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 7 OCT 2009

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Summary (61K)Standard (284K)Full (294K)

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via Athens http://onlinelibrary.wiley.com/athens or other institutional login options http://onlinelibrary.wiley.com/login-options .
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

View Full Article (HTML) Summary (61K)Standard (284K)Full (294K)